EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes

Benan Kartal, Christopher S Garris, Hyung Shik Kim, Rainer H Kohler, Jasmine Carrothers, Elias A Halabi, Yoshiko Iwamoto, Anne-Gaëlle Goubet, Yuxuan Xie, Pratyaksha Wirapati, Mikaël J Pittet, Ralph Weissleder

Advanced Science · 2025-01 · 12 (4)

DOI: 10.1002/advs.202410360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 05.12.2024. Verfasst von Benan Kartal und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA. Hauptthemen laut MEDLINE: Osteopontin, Tumor-Associated Macrophages, Myeloid Cells, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Studienstiftung des Deutschen Volkes (BK), Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secreted phosphosprotein 1 (SPP1) High tumor‐associated macrophages (TAM) are abundant tumor myeloid cells that are immunosuppressive, pro‐tumorigenic, and have a highly negative prognostic factor. Despite this, there is a lack of efficient TAM‐specific therapeutics capable of reducing SPP1 expression. Here, on a phenotypic screen is reported to identify small molecule SPP1 modulators in macrophages. Several hits and incorporated them into a TAM‐avid systemic nanoformulation are identified. It is shown that the lead compound (CANDI460) can down‐regulate SPP1 in vitro and in vivo and lead to tumor remissions in different murine models. These findings are important as they offer a promising avenue for developing novel therapeutic strategies targeting TAM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopontinTumor-Associated MacrophagesMyeloid CellsNeoplasmsAnimalsMiceHumansCell Line, TumorMacrophages

Stichwörter der Autor:innen

SPP1cancermacrophagenanoparticles

Substanzen

Osteopontin

Autor:innen und Institutionen

  • Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge St, CPZN 5206, Boston, MA, 02114, USA.
  • Department of Pathology and Immunology, University of Geneva, Geneva, 1211, Switzerland.
  • AGORA Cancer Research Center, Swiss Cancer Center Leman, Lausanne, 1011, Switzerland.
  • Ludwig Institute for Cancer Research, Lausanne, 1005, Switzerland.
  • Department of Systems Biology, Harvard Medical School, 200 Longwood Ave, Boston, MA, 02115, USA.

Förderung

  • NCI NIH HHS
  • Studienstiftung des Deutschen Volkes (BK)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • National Cancer Institute

Zitieren

APA

Kartal, B., Garris, C. S., Kim, H. S., Kohler, R. H., Carrothers, J., Halabi, E. A., Iwamoto, Y., Goubet, A. G., Xie, Y., Wirapati, P., Pittet, M. J., & Weissleder, R. (2025). Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes. Advanced Science, 12(4). https://doi.org/10.1002/advs.202410360

Vancouver

Kartal B, Garris CS, Kim HS, Kohler RH, Carrothers J, Halabi EA, et al. Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes. Advanced Science. 2025;12(4). doi:10.1002/advs.202410360

BibTeX
@article{Kartal2025,
  author = {Kartal, Benan and Garris, Christopher S and Kim, Hyung Shik and Kohler, Rainer H and Carrothers, Jasmine and Halabi, Elias A and Iwamoto, Yoshiko and Goubet, Anne-Gaëlle and Xie, Yuxuan and Wirapati, Pratyaksha and Pittet, Mikaël J and Weissleder, Ralph},
  title = {Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {4},
  doi = {10.1002/advs.202410360}
}
Kostenlos starten →